Summary.-The immunogenicity of murine leukaemias induced by chemical carcinogens or irradiation in C57B1 or (C57B1 x DBA2) Fl hybrid mice has been studied in vivo by transplantation and in vitro by indirect membrane immunofluorescence (IF) using syngeneic immune or allogeneic immune antisera. Two of 5 leukaemias tested for immunogenicity by assessment of the capacity of syngeneic mice specifically immunized with irradiated (3 Krad) cells to reject small challenge inocula (103-104 cells) displayed weak neoantigenicity while 3 were non-immunogenic by this criterion. Antibodies directed against cell-surface antigens of the immunizing cells of 7 leukaemias were not detectable by immunofluorescence tests using sera from the respective immunized mice. H-2 histocompatibility antigens readily identified on normal lymphoid cells using reference Balb/c anti-C57B1 (H-2d anti-H-2b) alloantisera could neither be detected on the majority of transplanted leukaemias nor on 9 primary leukaemias in C57BL mice induced by N-butyl-N-nitrosourea (BNU). Two of the transplanted leukaemias showed greatly diminished capacity for absorption of alloantibody compared with normal spleen cells. Transplantation to H-2 different recipients, in which the leukaemic cells were invariably rejected, generated a strong humoral antibody response, which was demonstrable against normal lymphoid cells.
Failure to demonstrate significant antibody binding by indirect immunofluorescence tests with immune sera, or by absorption, is presented as evidence that H-2 antigen expression is substantially modified on BNU induced leukaemia cells. These findings have implications for the detection of tumour neoantigens on chemically induced leukaemias.
MALIGNANT transformation is accompanied by a number of cell-surface modifications (Doljanski, 1973) . Such changes may include expression ofneoantigens which are clearly demonstrable by rejection of transplanted tumour cells in appropriately immunized hosts and by different serological procedures, as well as variations in the expression of normal histocompatibility antigens (Haywood and McKhann, 1971; Baldwin and Glaves, 1972) . Studies on neoantigen expression have been extended in recent years to many diverse host tumour systems (Klein, 1968) while modification of normal cell surface components has received less attention (Seigler et al., 1971) .
In experimental leukaemogenesis, cell surface antigenic changes in neoplasms induced by oncornaviruses have been relatively well documented (Aoki et al., 1970; Aoki and Takahashi, 1972; Boyse and Old, 1969; Stockert, Old and Boyse, 1971) . Information on the cell surface antigenic properties of chemically induced leukaemias other than those with a long history of transplantation (Rubin et al., 1970 ) is more restricted. However, quantitative variations in cell-surface antigens specified by the principal mouse *Sllpl)ort(ed by grants fiom the Medlical Research Couincil an(1 the Cancer Research Campaign. histocompatibility locus (H-2) on murine leukaemias induced by 7, 12-dimethylbenz (a)anthracene, have been described recently (Motta and Bruley, 1973) .
The objective of the present study was to examine the nature of the antigenic changes in the cell surface of murine lymphoid cells which had undergone malignant transformation in vivo by N-butyl-N-nitrosourea (BNU). Data initially acquired from transplantation tests in syngeneic hosts indicated that new cellular antigens could not be unequivocally detected on the surface of several leukaemias induced by this compound or on one leukaemia of radiogenic origin. These findings prompted a more extensive enquiry into whether the determination of neoantigenicity might be influenced, at least in part, by more complex changes at the cell surface affecting expression of normal histocompatibility antigens.
MATERIALS AND METHODS
Mice.-Inbred C57B1/6J and DBA2/J mice were originally obtained from the Jackson Laboratory and maintained in our own colony by brother-sister mating. B6D2F, (hereafter referred to as BDF1) mice are the Fl progeny of C57B1/6J female mice and DBA2/J males and were bred at the Paterson Laboratories.
Leukaemias.-Details of the 8 transplanted leukaemias used in these experiments are given in Table I . Leukaemia lines were maintained in vivo by serial intravenous inoculation of syngeneic mice with 106 leukaemic spleen cells about every 10 days.
Primary leukaemias were induced in C57B1 and BDF1 mice by continuous oral administration of N-butyl-N-nitrosourea (BNU) in the drinking water at a dose level of 200 mg/1-1. To each litre of BNU solution IN HCl (1 ml) and commercial Milton solution (1 ml) were added giving a pH of 4, to stabilize the compound. In this solution 97% of the BNU remained unchanged after 3 days at room temperature. The mice were given fresh solution 3 times each week. This treatment resulted in a 100% incidence of leukaemia, with a mean induction time of about 130 days.
The most common morphological features of these leukaemias were a large thymic tumour, which occurred in 65% of the treated animals, and splenomegaly which was also seen in 65%. Lymph node involvement was not very marked and occurred in 31 % of BNU treated mice. Hepatomegaly was less frequent and was found in only 26% ofthe mice.
Transplantation immunity studies
Five leukaemia lines, HII, HIV, CV, RI and P388 were used and cell suspensions prepared from normal and leukaemic spleens were subjected to 3 Krad y-radiation to produce mitotic inactivationt. Groups of syn- 3-methylcholanthrene in vivo * P388 leukaemia was derived from a 3-methylcholanthrene induced lymphoid tumour in a DBA2 mouse which was converted to ascitic form in the first transfer (Dawe and Potter, 1957) . P388 cells have been cultured in suspension in vitro at the Paterson Laboratories for a number of years (Fox and Gilbert, 1966) but will grow as a lymphoid tumour when injected intravenously into DBA2 mice. The mouse boxes were examined daily and mortalities were recorded. The mean survival time for each experimental group was calculated and compared with that of the controls.
A further 8 groups of 5 mice each were immunized with 4 doses of 107 radiation inactivated syngeneic leukaemic cells according to the above schedule. The leukaemia lines Al and ElI were used in addition to the above 5 lines. Ten days after the final injection the mice were bled from the retroorbital venous plexus and the syngeneic leukaemic antisera were separated and stored at -20°C. A normal serum control for each leukaemia was included. The reactivity of these sera with the respective immunizing leukaemias was tested by indirect membrane immunofluorescence (IF) .
Immunofluorescence studies Cell suspensions of high viability (>95%) were prepared from normal lymphoid organs and from grossly macroscopically involved leukaemic tissue by a teasing technique followed by passsage through fine metal gauze to remove non-dissociated material. The method modified by Moller (1961) for use with cells in suspension was employed. Aliquots of 1 ml of cell suspension, containing 5 x 106 to 107 cells ml-1 were centrifuged at 800 g for 3 min in small glass tubes. The cells were washed once in PBS and sedimented by centrifugation as before. Antiserum (0-1 ml ) was added to each tube. The cells were re-suspended in serum and incubated at 4°C for 20 min and then washed 3 times in PBS. Fluoresceinated horse anti-mouse IgG (Progressive Laboratories Inc., Baltimore, USA) was diluted -and 0 1 ml was added to each tube. The cells were re-suspended and incubated for 20 min as before. After a further 3 washings 0 1 ml 50% glycerol-saline (v/v) solution was added to each tube and the cells were examined under a coverslip using a Wild M20 fluorescence microscope, equipped with an HBO 200 mercury vapour lamp and the following filters: heat absorbing filter KG1; u.v. fluorescence exciting filter UGI (twice) and FITC; red absorbing filter BG38 and a colourless barrier filter, GG13c.
Cells exhibiting degrees of membrane staining from more than 2 isolated points on the cell surface to complete ring reactions were scored as positive.
A total of about 200 cells per tube were counted and the fluorescence index for each was calculated from the formula: Fluorescence Index (Fl)= % unstained cells in control-%unstained in test % unstained in control H-2 alloantisera.-Antisera were raised primarily against antigens of the principal mouse histocompatibility locus (H-2). The H-2 genotypes of the donor and recipient mice are given in Table II . Allogeneic mice were immunized with a minimum of 4 i.p. inoculations of 107 donor spleen cells at 10-day intervals. The mice were bled 10 days after the final immunization and the separated sera from identical groups of mice were pooled. Fluorescence indices for neat alloantisera were invariably >0 95, but diminished to 01 at dilutions of 1/100 or greater. Routinely, alloantisera were used at a 1 dilution which gave FT values against normal spleen cells in the range 0-6 to 0-8. Alloantisera against 3 leukaemias transplanted in syngeneic C57B1 (H-2b) 
DISCUSSION
The disclosure of significant differences in expression of antigenic components on the surface of leukaemic and normal murine lymphoid cells is dependent on reliable and sensitive methods for antigen detection. In the study of the cell-surface antigens of leukaemic cells two techniques have principally been used, viz. complement dependent immune cytolysis and membrane immunofluorescence (IF). Neither of these methods is without disadvantages; immune cytolysis is a complex process dependent not only on antibody binding but also on complement activation as well as properties related to membrane vulnerability and ability of cells to repair membrane damage (Lerner, Oldstone and Cooper, 1971) . Membrane immunofluorescence, on the other hand, is a sensitive and technically facile method although evaluation of results depends on visual observations that are not readily quantified. Whilst recognizing these limitations, the results presented in this paper were obtained using the latter technique and purport to show that, in comparison with normal lymphoid cells, there is gross modification of surface antigen expression on radiation and chemically-induced leukaemic cells. These conclusions are based principally on the findings that H-2 alloantisera capable of detecting H-2 antigens on the surface of normal cells from different lymphoid organs with an appreciable degree of sensitivity failed to reveal comparable antibody binding to the tumour cells; and also the demonstration of residual antibody reactivity against normal lymphoid cells following absorption of reference alloantisera with graded numbers of leukaemic cells. In some instances, such cell surface changes may be related to serial in vivo passage, or in the case of P388, to maintenance in tissue culture. While this possibility cannot be excluded for the transplanted leukaemias studied, a close association with leukaemogenesis is strongly implied by the finding that similar modification of H-2 antigen expression was a feature common to 9 BNU induced primary leukaemias.
There (Rubin et al., 1970; Seigler et al., 1971) while in other cases a general diminution, without detectable qualitative loss, has been reported (Haywood and McKhann, 1971) .
No information is available on the minimum antigen density required for detection of cell surface components by IF. It is possible that the five-fold increase in surface area of the leukaemic cells compared with normal lymphoid cells might reduce the capability of the test. However, this was not supported by absorption studies where exposure of antiserum to a surface area of leukaemic cells approximately 5 times that of normal spleen cells failed to abolish the reactivity of antibody with normal lymphoid cells.
The possibility that H-2 antigens on the surface of leukaemic cells are nonexposed or present in cryptic form merits consideration. Treatment of certain cell types with neuraminidase reveals otherwise concealed histocompatibility antigens, as demonstrated by increased susceptibility of cells to the appropriate antibody in vitro and abrogation of allogeneic transplantability in vivo (Sanford, 1967; Schlesinger and Amos, 1971; Schlesinger and Gottesfeld, 1971 ). Masking phenomena other than sialic acid coating are known to exist (Friberg and Lilliehook, 1973) . In several mouse tumour systems failure to detect H-2 antigens, shown by cell fractionation procedures to be localized exclusively in the cell membrane, was attributed to steric hindrance of cell surface determinants in the leukaemic cells (Molnar, Klein and Friberg, 1973) . Masking of antigen, as distinct from deletion, possibly accounts more adequately for the humoral antibody response generated against H-2 antigens in allogeneic mice. However, the degree to which unavoidable contamination of the immunizing leukaemia cell preparations with a small minority of normal lymphoid cells contributes to this antibody induction is difficult to assess quantitatively and should not be disregarded.
Most experimentally induced leukaemias express neoantigens detectable serologically or by in vivo transplantation procedures (Pasternak, 1969) . In the present study only 2 of 5 transplanted leukaemias provided any evidence of immunogenicity, and this was weak. The association of this property with P388 leukaemia cells in particular is obscure. This might reflect histocompatibility differences between tumour and host, culminating from a long history of transplantation and in vitro culture, or antigenic conversion (Stuck, Old and Boyse, 1964) , an interpretation consistent with the large numbers of virus particles associated with this neoplasm (T. D. Allen, personal communication).
Attempts to induce resistance against 3 other transplanted leukaemias in this study were unsuccessful. Several possibilities might account for this apparent lack of neoantigenicity, e.g. the deficiency may be intrinsic or a consequence of immuno selection. However, since some murine lymphomata exist for which the LD50 in syngeneic recipients is only a few cells, the requirement of 103 cells to ensure leukaemia development implies some resistance on the part of the host. This being so, failure to significantly augment this protection by immunization, other than in an apparently nonspecific way, or to induce synthesis of specific antibody, may be a reflection of the inadequacy of the immunization protocol rather than lack of immunogenicity. However, alternative methods of inducing resistance or raising antibody using mitomycin-C treated cells or subthreshold inocula have not proved cignificantly better (unpublished finding}. These data would not therefore be inconconsistent with the hypothesis that failure to detect unequivocally tumour neoantigens on these leukaemias is related to complex cell surface changes affecting antigen expression as a whole.
